List of Tables
    Table 1. Cancer Biological Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cancer Biological Therapy Market Trends
    Table 3. Cancer Biological Therapy Market Drivers
    Table 4. Cancer Biological Therapy Market Challenges
    Table 5. Cancer Biological Therapy Market Restraints
    Table 6. Global Cancer Biological Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Biological Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Biological Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Biological Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Biological Therapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Biological Therapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cancer Biological Therapy Revenue Share by Player, 2017-2022
    Table 13. Global Cancer Biological Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cancer Biological Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021)
    Table 15. Top Players of Cancer Biological Therapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cancer Biological Therapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cancer Biological Therapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cancer Biological Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cancer Biological Therapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cancer Biological Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cancer Biological Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cancer Biological Therapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cancer Biological Therapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. ELI Lilly Company Details
    Table 31. ELI Lilly Business Overview
    Table 32. ELI Lilly Cancer Biological Therapy Product
    Table 33. ELI Lilly Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 34. ELI Lilly Recent Development
    Table 35. Sanofi Company Details
    Table 36. Sanofi Business Overview
    Table 37. Sanofi Cancer Biological Therapy Product
    Table 38. Sanofi Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 39. Sanofi Recent Development
    Table 40. Merck Company Details
    Table 41. Merck Business Overview
    Table 42. Merck Cancer Biological Therapy Product
    Table 43. Merck Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 44. Merck Recent Development
    Table 45. Bayer Company Details
    Table 46. Bayer Business Overview
    Table 47. Bayer Cancer Biological Therapy Product
    Table 48. Bayer Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 49. Bayer Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Cancer Biological Therapy Product
    Table 53. Roche Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Novartis International Company Details
    Table 56. Novartis International Business Overview
    Table 57. Novartis International Cancer Biological Therapy Product
    Table 58. Novartis International Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 59. Novartis International Recent Development
    Table 60. Pfizer Company Details
    Table 61. Pfizer Business Overview
    Table 62. Pfizer Cancer Biological Therapy Product
    Table 63. Pfizer Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 64. Pfizer Recent Development
    Table 65. Bristol-Myers Squibb Company Details
    Table 66. Bristol-Myers Squibb Business Overview
    Table 67. Bristol-Myers Squibb Cancer Biological Therapy Product
    Table 68. Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 69. Bristol-Myers Squibb Recent Development
    Table 70. Seattle Genetics Company Details
    Table 71. Seattle Genetics Business Overview
    Table 72. Seattle Genetics Cancer Biological Therapy Product
    Table 73. Seattle Genetics Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 74. Seattle Genetics Recent Development
    Table 75. Amgen Company Details
    Table 76. Amgen Business Overview
    Table 77. Amgen Cancer Biological Therapy Product
    Table 78. Amgen Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 79. Amgen Recent Development
    Table 80. Takeda Pharmaceuticals Company Details
    Table 81. Takeda Pharmaceuticals Business Overview
    Table 82. Takeda Pharmaceuticals Cancer Biological Therapy Product
    Table 83. Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 84. Takeda Pharmaceuticals Recent Development
    Table 85. GlaxoSmithKline Company Details
    Table 86. GlaxoSmithKline Business Overview
    Table 87. GlaxoSmithKline Cancer Biological Therapy Product
    Table 88. GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 89. GlaxoSmithKline Recent Development
    Table 90. Spectrum Pharmaceuticals Company Details
    Table 91. Spectrum Pharmaceuticals Business Overview
    Table 92. Spectrum Pharmaceuticals Cancer Biological Therapy Product
    Table 93. Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 94. Spectrum Pharmaceuticals Recent Development
    Table 95. Celgene Corporation Company Details
    Table 96. Celgene Corporation Business Overview
    Table 97. Celgene Corporation Cancer Biological Therapy Product
    Table 98. Celgene Corporation Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 99. Celgene Corporation Recent Development
    Table 100. AstraZeneca, Plc. Company Details
    Table 101. AstraZeneca, Plc. Business Overview
    Table 102. AstraZeneca, Plc. Cancer Biological Therapy Product
    Table 103. AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 104. AstraZeneca, Plc. Recent Development
    Table 105. Otsuka Company Details
    Table 106. Otsuka Business Overview
    Table 107. Otsuka Cancer Biological Therapy Product
    Table 108. Otsuka Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 109. Otsuka Recent Development
    Table 110. Eisai Company Details
    Table 111. Eisai Business Overview
    Table 112. Eisai Cancer Biological Therapy Product
    Table 113. Eisai Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 114. Eisai Recent Development
    Table 115. Abbvie Company Details
    Table 116. Abbvie Business Overview
    Table 117. Abbvie Cancer Biological Therapy Product
    Table 118. Abbvie Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 119. Abbvie Recent Development
    Table 120. Incyte Company Details
    Table 121. Incyte Business Overview
    Table 122. Incyte Cancer Biological Therapy Product
    Table 123. Incyte Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 124. Incyte Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Biological Therapy Product Picture
    Figure 2. Global Cancer Biological Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Biological Therapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cancer Biological Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cancer Biological Therapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cancer Biological Therapy Market Share in Global 2017-2028
    Figure 7. Cancer Biological Therapy Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibodies
    Figure 9. Product Picture of Vaccines
    Figure 10. Product Picture of Cancer Growth Blockers
    Figure 11. Product Picture of Blood Cell Growth Factors
    Figure 12. Global Cancer Biological Therapy Market Share by Type in 2022 & 2028
    Figure 13. Global Cancer Biological Therapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Cancer Biological Therapy Market Share by Type (2017-2028)
    Figure 15. United States Cancer Biological Therapy Market Share by Type in 2022 & 2028
    Figure 16. United States Cancer Biological Therapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Cancer Biological Therapy Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Diagnostic Laboratories
    Figure 20. Product Picture of Research & Academic Laboratories
    Figure 21. Product Picture of Pharmaceutical & Biotechnology Companies
    Figure 22. Global Cancer Biological Therapy Market Share by Application in 2022 & 2028
    Figure 23. Global Cancer Biological Therapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Cancer Biological Therapy Market Share by Application (2017-2028)
    Figure 25. United States Cancer Biological Therapy Market Share by Application in 2022 & 2028
    Figure 26. United States Cancer Biological Therapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Cancer Biological Therapy Market Share by Application (2017-2028)
    Figure 28. North America Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 57. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 59. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 60. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 61. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 62. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 64. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 65. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 66. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 69. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 70. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 71. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 72. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 73. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 74. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed